News
Overcoming Challenges in CAR-T Therapy for T-Cell Blood Cancers
While CAR-T therapy has revolutionized the treatment of B-cell cancers, significant challenges remain in treating T-cell malignancies. A recent review explores the complexities of CAR-T therapy in T-cell blood cancers and potential solutions to overcome these obstacles.
Advancements in First-Line Treatment for Adult B-ALL: A Comprehensive Review from The Lancet Haematology
A recent review in The Lancet Haematology highlights significant progress in the first-line treatment of newly diagnosed adult B-cell Acute Lymphoblastic Leukemia (B-ALL), focusing on personalized treatment approaches, novel immunotherapies, and improved patient outcomes.
A Teen Reclaims Hope After AML M4a Diagnosis A Journey of Resilience and Recovery
After battling acute myeloid leukemia (AML-M4a) and undergoing a life-saving stem cell transplant, a young patient finds hope, health, and a new beginning, thanks to the exceptional care of Lu Daopei Hospital.
New Advances in Primary Central Nervous System Lymphoma (PCNSL) Treatment and Diagnosis
Recent progress in the diagnosis and treatment of Primary Central Nervous System Lymphoma (PCNSL) has offered new hope for patients. A recent review from Stanford University highlights the importance of early diagnosis and the latest treatment options, including chemotherapy and targeted therapies.
Patient Story: Overcoming Acute Myeloid Leukemia and Rebirth After Stem Cell Transplant
A 34-year-old male patient shares his inspiring journey of battling acute myeloid leukemia (AML), undergoing multiple rounds of chemotherapy and a stem cell transplant, and celebrating three years of recovery and renewed hope.
Clinical Significance of Oligoclonal Protein Bands After BCMA CAR-T Therapy in Multiple Myeloma Patients
A retrospective study evaluates the incidence and implications of oligoclonal protein bands (APB) in relapsed/refractory multiple myeloma (MM) patients treated with LCAR-B38M CAR-T therapy, highlighting their correlation with improved outcomes.
Patient Story: From AML-M2 Diagnosis to a University Freshman – A Five-Year Journey to Recovery
A young leukemia patient’s five-year battle against AML-M2, culminating in a successful haploidentical stem cell transplant at Lu Daopei Hospital, paves the way for his new life as a university student.
Multi-Center Study Shows Good Prognosis for Hematologic Malignancy Patients Undergoing MMUD Allogeneic Stem Cell Transplant with ATG
A large multi-center study in China reveals positive outcomes for patients with hematologic malignancies undergoing mismatched unrelated donor (MMUD) stem cell transplants with ATG for GVHD prevention
Patient Story: High-Risk B-ALL, Bone Marrow Transplant at 9 Months, Two Years Later—A Healthy Start for a Young Fighter
A 9-month-old child, diagnosed with high-risk Acute B Lymphoblastic Leukemia (B-ALL), undergoes a successful bone marrow transplant. Two years later, the child is thriving and ready for kindergarten.
Accelerating CAR-T Cell Preparation to Enhance Patient Outcomes
A recent review in The Lancet Haematology highlights innovative advancements in CAR-T cell therapy, focusing on optimizing production speed, improving treatment efficacy, and expanding accessibility for patients with blood and solid tumors.
Brexu-cel CAR-T Therapy Shows Promising Results in Adult R/R B-ALL Patients
A recent study in the Journal of Clinical Oncology reports positive outcomes for CD19 CAR-T therapy brexucabtagene autoleucel (brexu-cel) in treating relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL), offering hope for high remission rates and improved survival in real-world settings.
Understanding Thalassemia: A Comprehensive Guide to Alpha and Beta Forms
Thalassemia is more than one disease. This guide explores both alpha and beta thalassemia, their causes, symptoms, and the latest treatment options available at BIOOCUS International Medical Center.